We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+18.5%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
–
AUM
$15.5B
AUM Growth
+$2.94B
Cap. Flow
+$1.45B
Cap. Flow %
9.35%
Top 10 Hldgs %
30.63%
Holding
2,230
New
735
Increased
384
Reduced
378
Closed
720

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$614M
2
AAPL icon
Apple
AAPL
+$443M
3
BLD
TopBuild
BLD
+$391M
4
SPCX
SpaceX
SPCX
+$329M
5
PEN icon
Penumbra
PEN
+$203M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.96B
2
NVDA icon
NVIDIA
NVDA
+$425M
3
SNDK
Sandisk
SNDK
+$88M
4
SO icon
Southern Company
SO
+$80.6M
5
PPL
PPL Corp
PPL
+$74.1M

Sector Composition

Rank Sector Weight
1 Technology 16.4%
2 Industrials 13.64%
3 Consumer Discretionary 9.5%
4 Healthcare 7.9%
5 Financials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADI icon
451
Analog Devices
ADI
$182B
$5.77M 0.04%
14,522
-84,090
-85% -$33.3M
TKR icon
452
Timken Company
TKR
$8.67B
$5.72M 0.04%
+39,363
New +$4.73M
CRWD icon
453
CrowdStrike
CRWD
$195B
$5.72M 0.04%
29,964
-34,368
-53% -$4.88M
MO icon
454
Altria Group
MO
$110B
$5.71M 0.04%
+79,339
New +$5.54M
AHR icon
455
American Healthcare REIT
AHR
$12.2B
$5.64M 0.04%
+108,098
New +$5.31M
T icon
456
AT&T
T
$173B
$5.61M 0.04%
271,096
+216,892
+400% +$5.38M
SSD icon
457
Simpson Manufacturing
SSD
$7.74B
$5.59M 0.04%
26,723
+19,532
+272% +$3.65M
CMS icon
458
CMS Energy
CMS
$21.4B
$5.58M 0.04%
72,938
-331,310
-82% -$24.8M
ALSN icon
459
Allison Transmission
ALSN
$11B
$5.55M 0.04%
49,222
+31,790
+182% +$3.86M
TVTX icon
460
Travere Therapeutics
TVTX
$6.19B
$5.54M 0.04%
97,442
+23,532
+32% +$1.04M
VCYT icon
461
Veracyte
VCYT
$3.4B
$5.52M 0.04%
+94,044
New +$3.94M
SNDR icon
462
Schneider National
SNDR
$6.28B
$5.49M 0.04%
150,413
-39,192
-21% -$1.28M
ALG icon
463
Alamo Group
ALG
$2B
$5.49M 0.04%
33,379
+29,530
+767% +$4.78M
DCO icon
464
Ducommun
DCO
$2.89B
$5.48M 0.04%
29,591
-2,503
-8% -$371K
EXPD icon
465
Expeditors International
EXPD
$24.4B
$5.48M 0.04%
+33,620
New +$5.2M
USFD icon
466
PUT
US Foods
USFD
$23.7B
$5.47M 0.04%
+53,500
New +$4.77M
MAZE
467
Maze Therapeutics
MAZE
$1.63B
$5.47M 0.04%
+183,264
New +$4.8M
DELL icon
468
Dell
DELL
$286B
$5.41M 0.03%
+12,538
New +$3.63M
TMHC
469
DELISTED
Taylor Morrison
TMHC
$5.41M 0.03%
75,380
+35,207
+88% +$2.24M
CFR icon
470
Cullen/Frost Bankers
CFR
$10.2B
$5.4M 0.03%
+34,929
New +$4.96M
KNSL icon
471
Kinsale Capital Group
KNSL
$8.74B
$5.39M 0.03%
16,350
+15,361
+1,553% +$4.94M
TWST icon
472
Twist Bioscience
TWST
$9.13B
$5.35M 0.03%
+51,999
New +$3.38M
IRT icon
473
Independence Realty Trust
IRT
$3.91B
$5.35M 0.03%
+320,290
New +$5.18M
TIGO icon
474
Millicom
TIGO
$15.7B
$5.29M 0.03%
58,268
-67,235
-54% -$5.66M
BRX icon
475
Brixmor Property Group
BRX
$8.99B
$5.28M 0.03%
167,399
-34,965
-17% -$1.07M
17 18
19
20 21

Similar funds

FGP
Freestone Grove Partners San Francisco, California $15.6B AUM 27.39% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
AA
Acorns Advisers Irvine, California $15.3B AUM 18.32% 1-Year Est. Return
OTPPB
Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $15.8B AUM 1.29% 1-Year Est. Return
NMIFOAC
National Mutual Insurance Federation of Agricultural Cooperatives Tokyo, Japan, Japan $15.3B AUM 24.71% 1-Year Est. Return

Michael Gelband's Q2 2026 Portfolio in Review

As of Q2 2026, Michael Gelband held 2,230 positions worth $15.5B, up 23% from $12.6B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Michael Gelband deployed $1.45B of net new capital in Q2 2026, opening 735 new positions and adding to 384 existing holdings. Its largest new stake was SpaceX: 1,938,935 shares worth $331M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Tesla, an estimated $1.96B trimmed.

  • Michael Gelband's largest Q2 2026 buy was SpaceX: 1,938,935 shares worth $331M.
  • Michael Gelband added most to Amazon in Q2 2026, an estimated $614M increase.
  • Michael Gelband's biggest Q2 2026 reduction was Tesla, cutting an estimated $1.96B.
  • Michael Gelband fully exited Southern Company in Q2 2026, selling an estimated $80.6M.
  • Michael Gelband's ten largest holdings make up 31% of its $15.5B portfolio in Q2 2026.
  • Michael Gelband opened 735 new positions and closed 720 in Q2 2026.
  • Michael Gelband's portfolio value rose 23% quarter-over-quarter to $15.5B.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.